ArticlePloS one2025
Impact of substrate choice on human osteoclast differentiation and secretome: Implications for targeted therapeutic development.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoclasts (OCs) exhibit substrate-specific molecular adaptations crucial for bone remodeling. We utilized mass spectrometry and functional enrichment analysis to delineate the proteomic profiles of mature polarized OCs cultured on mineralized versus plastic plates. Our findings reveal that mineralized surfaces promote the expression of proteins specialized for bone resorption and matrix interaction, such as lysosomal enzymes and ion transporters. This environment induces a mature and resorptive phenotype in OCs, enriched in pathways like VEGF/VEGFR signaling and various cytokine pathways. Conversely, OCs on plastic plates display a more diverse proteomic profile, highlighting adaptations in adhesion, proliferation, and stress response pathways, suggesting a focus on cellular maintenance rather than active resorption. Key therapeutic targets for osteoclastogenesis include components of the Hedgehog (Hh) pathway-SHH, DHH, and IHH-with Smoothened (SMO) integral to Hh signaling in OC differentiation. Additionally, Guanine Nucleotide Exchange Factors (GEFs), significantly enriched on plastic plates, are crucial for adapting to non-mineralized environments. Other notable targets include molecular regulators such as NCOR2, which modulates gene expression; NOS1, involved in nitric oxide production and OC function; and XIAP, which influences cell survival. Chromatin remodeling proteins like TACC2 and signaling pathways involving IRS1, MSX1, and AKT are also highlighted. The targets identified in this study are specific to polarized OCs and may not apply to non-polarized OCs or other cell types. These findings underscore the complexity of OC differentiation and function, enhancing our understanding of substrate-specific adaptations and suggesting new strategies for modulating bone metabolism and addressing bone-related disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.